APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaginitis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vaginitis Drug Industry Growth and Trends Forecast to 2032

20 December 2025121 pages

Choose your research edition.

Industry ResearchVaginitis Drug Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaginitis Drug Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Vaginitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaginitis Drug Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaginitis Drug Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

According to APO Research, the global Vaginitis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vaginitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vaginitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaginitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Vaginitis Drug market include Bausch Health, Dare Bioscience, Galderma, Globela Pharma, Lupin Pharmaceuticals, Padagis, Perrigo, Prestige Consumer Healthcare and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vaginitis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vaginitis Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaginitis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaginitis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Vaginitis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vaginitis Drug Market by Company

Bausch Health

Dare Bioscience

Galderma

Globela Pharma

Lupin Pharmaceuticals

Padagis

Perrigo

Prestige Consumer Healthcare

Sandoz

Bayer

Sinopharm Group

HCPC

CR-Double Crane Pharmaceuticals

Pfizer

Conba

Kelun Pharmaceuticals

Livzon Pharmaceuticals

Lukang Pharmaceuticals

Luoxin Pharmaceuticals

Johnson & Johnson

Sanofi

Shandong Shijiazhuang Pharmaceutical Group

Teva Pharmaceuticals

Tongfang Pharmaceuticals

Wuhan Haite Biopharmaceuticals

Yuanda Pharmaceuticals

Yunnan Baiyao

Vaginitis Drug Segment by Type

External Drug

Oral Drug

Vaginitis Drug Segment by Application

Hospital Phamacy

Retail Phamacy

Online

Vaginitis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaginitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaginitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaginitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Vaginitis Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Vaginitis Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Vaginitis Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Vaginitis Drug Market Share by Region (2021-2026) Table 4. Global Vaginitis Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Vaginitis Drug Market Share by Region (2027-2032) Table 6. Global Vaginitis Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Vaginitis Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Vaginitis Drug Market Size Share by Type (2021-2026) Table 9. Global Vaginitis Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Vaginitis Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Vaginitis Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Vaginitis Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Vaginitis Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Vaginitis Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Vaginitis Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Vaginitis Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Vaginitis Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Vaginitis Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Vaginitis Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Vaginitis Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Vaginitis Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Vaginitis Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Vaginitis Drug Market Size Share by Application (2021-2026) Table 24. Global Vaginitis Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Vaginitis Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Vaginitis Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Vaginitis Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Vaginitis Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Vaginitis Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Vaginitis Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Vaginitis Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Vaginitis Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Vaginitis Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Vaginitis Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Vaginitis Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Vaginitis Drug Industry Trends Table 37. Vaginitis Drug Industry Drivers Table 38. Vaginitis Drug Industry Opportunities and Challenges Table 39. Vaginitis Drug Industry Restraints Table 40. Global Vaginitis Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Vaginitis Drug Revenue Market Share by Company (2021-2026) Table 42. Global Vaginitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Vaginitis Drug Key Company Headquarters & Area Served Table 44. Global Vaginitis Drug Company, Product Type & Application Table 45. Global Vaginitis Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Vaginitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Bausch Health Company Information Table 49. Bausch Health Business Overview Table 50. Bausch Health Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Bausch Health Vaginitis Drug Product Portfolio Table 52. Bausch Health Recent Development Table 53. Dare Bioscience Company Information Table 54. Dare Bioscience Business Overview Table 55. Dare Bioscience Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Dare Bioscience Vaginitis Drug Product Portfolio Table 57. Dare Bioscience Recent Development Table 58. Galderma Company Information Table 59. Galderma Business Overview Table 60. Galderma Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Galderma Vaginitis Drug Product Portfolio Table 62. Galderma Recent Development Table 63. Globela Pharma Company Information Table 64. Globela Pharma Business Overview Table 65. Globela Pharma Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Globela Pharma Vaginitis Drug Product Portfolio Table 67. Globela Pharma Recent Development Table 68. Lupin Pharmaceuticals Company Information Table 69. Lupin Pharmaceuticals Business Overview Table 70. Lupin Pharmaceuticals Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Lupin Pharmaceuticals Vaginitis Drug Product Portfolio Table 72. Lupin Pharmaceuticals Recent Development Table 73. Padagis Company Information Table 74. Padagis Business Overview Table 75. Padagis Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Padagis Vaginitis Drug Product Portfolio Table 77. Padagis Recent Development Table 78. Perrigo Company Information Table 79. Perrigo Business Overview Table 80. Perrigo Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Perrigo Vaginitis Drug Product Portfolio Table 82. Perrigo Recent Development Table 83. Prestige Consumer Healthcare Company Information Table 84. Prestige Consumer Healthcare Business Overview Table 85. Prestige Consumer Healthcare Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Prestige Consumer Healthcare Vaginitis Drug Product Portfolio Table 87. Prestige Consumer Healthcare Recent Development Table 88. Sandoz Company Information Table 89. Sandoz Business Overview Table 90. Sandoz Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sandoz Vaginitis Drug Product Portfolio Table 92. Sandoz Recent Development Table 93. Bayer Company Information Table 94. Bayer Business Overview Table 95. Bayer Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Bayer Vaginitis Drug Product Portfolio Table 97. Bayer Recent Development Table 98. Sinopharm Group Company Information Table 99. Sinopharm Group Business Overview Table 100. Sinopharm Group Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sinopharm Group Vaginitis Drug Product Portfolio Table 102. Sinopharm Group Recent Development Table 103. HCPC Company Information Table 104. HCPC Business Overview Table 105. HCPC Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. HCPC Vaginitis Drug Product Portfolio Table 107. HCPC Recent Development Table 108. CR-Double Crane Pharmaceuticals Company Information Table 109. CR-Double Crane Pharmaceuticals Business Overview Table 110. CR-Double Crane Pharmaceuticals Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. CR-Double Crane Pharmaceuticals Vaginitis Drug Product Portfolio Table 112. CR-Double Crane Pharmaceuticals Recent Development Table 113. Pfizer Company Information Table 114. Pfizer Business Overview Table 115. Pfizer Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Pfizer Vaginitis Drug Product Portfolio Table 117. Pfizer Recent Development Table 118. Conba Company Information Table 119. Conba Business Overview Table 120. Conba Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Conba Vaginitis Drug Product Portfolio Table 122. Conba Recent Development Table 123. Kelun Pharmaceuticals Company Information Table 124. Kelun Pharmaceuticals Business Overview Table 125. Kelun Pharmaceuticals Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Kelun Pharmaceuticals Vaginitis Drug Product Portfolio Table 127. Kelun Pharmaceuticals Recent Development Table 128. Livzon Pharmaceuticals Company Information Table 129. Livzon Pharmaceuticals Business Overview Table 130. Livzon Pharmaceuticals Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Livzon Pharmaceuticals Vaginitis Drug Product Portfolio Table 132. Livzon Pharmaceuticals Recent Development Table 133. Lukang Pharmaceuticals Company Information Table 134. Lukang Pharmaceuticals Business Overview Table 135. Lukang Pharmaceuticals Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Lukang Pharmaceuticals Vaginitis Drug Product Portfolio Table 137. Lukang Pharmaceuticals Recent Development Table 138. Luoxin Pharmaceuticals Company Information Table 139. Luoxin Pharmaceuticals Business Overview Table 140. Luoxin Pharmaceuticals Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Luoxin Pharmaceuticals Vaginitis Drug Product Portfolio Table 142. Luoxin Pharmaceuticals Recent Development Table 143. Johnson & Johnson Company Information Table 144. Johnson & Johnson Business Overview Table 145. Johnson & Johnson Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Johnson & Johnson Vaginitis Drug Product Portfolio Table 147. Johnson & Johnson Recent Development Table 148. Sanofi Company Information Table 149. Sanofi Business Overview Table 150. Sanofi Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Sanofi Vaginitis Drug Product Portfolio Table 152. Sanofi Recent Development Table 153. Shandong Shijiazhuang Pharmaceutical Group Company Information Table 154. Shandong Shijiazhuang Pharmaceutical Group Business Overview Table 155. Shandong Shijiazhuang Pharmaceutical Group Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Shandong Shijiazhuang Pharmaceutical Group Vaginitis Drug Product Portfolio Table 157. Shandong Shijiazhuang Pharmaceutical Group Recent Development Table 158. Teva Pharmaceuticals Company Information Table 159. Teva Pharmaceuticals Business Overview Table 160. Teva Pharmaceuticals Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Teva Pharmaceuticals Vaginitis Drug Product Portfolio Table 162. Teva Pharmaceuticals Recent Development Table 163. Tongfang Pharmaceuticals Company Information Table 164. Tongfang Pharmaceuticals Business Overview Table 165. Tongfang Pharmaceuticals Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Tongfang Pharmaceuticals Vaginitis Drug Product Portfolio Table 167. Tongfang Pharmaceuticals Recent Development Table 168. Wuhan Haite Biopharmaceuticals Company Information Table 169. Wuhan Haite Biopharmaceuticals Business Overview Table 170. Wuhan Haite Biopharmaceuticals Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Wuhan Haite Biopharmaceuticals Vaginitis Drug Product Portfolio Table 172. Wuhan Haite Biopharmaceuticals Recent Development Table 173. Yuanda Pharmaceuticals Company Information Table 174. Yuanda Pharmaceuticals Business Overview Table 175. Yuanda Pharmaceuticals Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Yuanda Pharmaceuticals Vaginitis Drug Product Portfolio Table 177. Yuanda Pharmaceuticals Recent Development Table 178. Yunnan Baiyao Company Information Table 179. Yunnan Baiyao Business Overview Table 180. Yunnan Baiyao Vaginitis Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Yunnan Baiyao Vaginitis Drug Product Portfolio Table 182. Yunnan Baiyao Recent Development Table 183. North America Vaginitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. North America Vaginitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 185. North America Vaginitis Drug Market Share by Country (2021-2026) Table 186. North America Vaginitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. North America Vaginitis Drug Market Share Forecast by Country (2027-2032) Table 188. Europe Vaginitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Europe Vaginitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 190. Europe Vaginitis Drug Market Share by Country (2021-2026) Table 191. Europe Vaginitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Europe Vaginitis Drug Market Share Forecast by Country (2027-2032) Table 193. Asia-Pacific Vaginitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Asia-Pacific Vaginitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 195. Asia-Pacific Vaginitis Drug Market Share by Country (2021-2026) Table 196. Asia-Pacific Vaginitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Asia-Pacific Vaginitis Drug Market Share Forecast by Country (2027-2032) Table 198. Latin America Vaginitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Latin America Vaginitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 200. Latin America Vaginitis Drug Market Share by Country (2021-2026) Table 201. Latin America Vaginitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Latin America Vaginitis Drug Market Share Forecast by Country (2027-2032) Table 203. Middle East & Africa Vaginitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Middle East & Africa Vaginitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 205. Middle East & Africa Vaginitis Drug Market Share by Country (2021-2026) Table 206. Middle East & Africa Vaginitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Middle East & Africa Vaginitis Drug Market Share Forecast by Country (2027-2032) Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Vaginitis Drug Product Image Figure 3. Global Vaginitis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Vaginitis Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Vaginitis Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Vaginitis Drug Market Share by Region (2021-2032) Figure 7. North America Vaginitis Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Vaginitis Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Vaginitis Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Vaginitis Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Vaginitis Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. External Drug Image Figure 13. Global External Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Oral Drug Image Figure 15. Global Oral Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Vaginitis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Vaginitis Drug Market Share by Type 2025 VS 2032 Figure 18. North America Vaginitis Drug Market Size Share by Type (2021-2032) Figure 19. Europe Vaginitis Drug Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Vaginitis Drug Market Size Share by Type (2021-2032) Figure 21. Latin America Vaginitis Drug Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Vaginitis Drug Market Size Share by Type (2021-2032) Figure 23. Hospital Phamacy Image Figure 24. Global Hospital Phamacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Retail Phamacy Image Figure 26. Global Retail Phamacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Online Image Figure 28. Global Online Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Vaginitis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Vaginitis Drug Market Share by Application 2025 VS 2032 Figure 31. North America Vaginitis Drug Market Size Share by Application (2021-2032) Figure 32. Europe Vaginitis Drug Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Vaginitis Drug Market Size Share by Application (2021-2032) Figure 34. Latin America Vaginitis Drug Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Vaginitis Drug Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Vaginitis Drug Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Vaginitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Vaginitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Vaginitis Drug Market Share by Country (2021-2032) Figure 41. Europe Vaginitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Vaginitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Vaginitis Drug Market Share by Country (2021-2032) Figure 44. Asia-Pacific Vaginitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Vaginitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Vaginitis Drug Market Share by Country (2021-2032) Figure 47. Latin America Vaginitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Vaginitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Vaginitis Drug Market Share by Country (2021-2032) Figure 50. Middle East & Africa Vaginitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Vaginitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Vaginitis Drug Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • External Drug
  • Oral Drug
Applications
  • Hospital Phamacy
  • Retail Phamacy
  • Online
Companies covered
  • Bausch Health
  • Dare Bioscience
  • Galderma
  • Globela Pharma
  • Lupin Pharmaceuticals
  • Padagis
  • Perrigo
  • Prestige Consumer Healthcare
  • Sandoz
  • Bayer
  • Sinopharm Group
  • HCPC
  • CR-Double Crane Pharmaceuticals
  • Pfizer
  • Conba
  • Kelun Pharmaceuticals
  • Livzon Pharmaceuticals
  • Lukang Pharmaceuticals
  • Luoxin Pharmaceuticals
  • Johnson & Johnson
  • Sanofi
  • Shandong Shijiazhuang Pharmaceutical Group
  • Teva Pharmaceuticals
  • Tongfang Pharmaceuticals
  • Wuhan Haite Biopharmaceuticals
  • Yuanda Pharmaceuticals
  • Yunnan Baiyao

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Vaginitis Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Vaginitis Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Vaginitis Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Vaginitis Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Vaginitis Drug Market Size (2021-2032)
  8. 1.5.1 North America Vaginitis Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Vaginitis Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Vaginitis Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Vaginitis Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Vaginitis Drug Market Size Growth Rate (2021-2032)
2 Vaginitis Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 External Drug
  3. 2.1.2 Oral Drug
  4. 2.2 Global Vaginitis Drug Market Size by Type
  5. 2.2.1 Global Vaginitis Drug Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Vaginitis Drug Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Vaginitis Drug Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Vaginitis Drug Market Size by Regions
  9. 2.3.1 North America Vaginitis Drug Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Vaginitis Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Vaginitis Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Vaginitis Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Vaginitis Drug Market Size Breakdown by Type (2021-2026)
3 Vaginitis Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Phamacy
  3. 3.1.2 Retail Phamacy
  4. 3.1.3 Online
  5. 3.2 Global Vaginitis Drug Market Size by Application
  6. 3.2.1 Global Vaginitis Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Vaginitis Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Vaginitis Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Vaginitis Drug Market Size by Regions
  10. 3.3.1 North America Vaginitis Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Vaginitis Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Vaginitis Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Vaginitis Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Vaginitis Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Vaginitis Drug Industry Trends
  2. 4.2 Vaginitis Drug Industry Drivers
  3. 4.3 Vaginitis Drug Industry Opportunities and Challenges
  4. 4.4 Vaginitis Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Vaginitis Drug Revenue (2021-2026)
  2. 5.2 Global Vaginitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Vaginitis Drug Key Company Headquarters & Area Served
  4. 5.4 Global Vaginitis Drug Company, Product Type & Application
  5. 5.5 Global Vaginitis Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Vaginitis Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Vaginitis Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Vaginitis Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Bausch Health
  2. 6.1.1 Bausch Health Company Information
  3. 6.1.2 Bausch Health Business Overview
  4. 6.1.3 Bausch Health Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Bausch Health Vaginitis Drug Product Portfolio
  6. 6.1.5 Bausch Health Recent Developments
  7. 6.2 Dare Bioscience
  8. 6.2.1 Dare Bioscience Company Information
  9. 6.2.2 Dare Bioscience Business Overview
  10. 6.2.3 Dare Bioscience Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Dare Bioscience Vaginitis Drug Product Portfolio
  12. 6.2.5 Dare Bioscience Recent Developments
  13. 6.3 Galderma
  14. 6.3.1 Galderma Company Information
  15. 6.3.2 Galderma Business Overview
  16. 6.3.3 Galderma Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Galderma Vaginitis Drug Product Portfolio
  18. 6.3.5 Galderma Recent Developments
  19. 6.4 Globela Pharma
  20. 6.4.1 Globela Pharma Company Information
  21. 6.4.2 Globela Pharma Business Overview
  22. 6.4.3 Globela Pharma Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Globela Pharma Vaginitis Drug Product Portfolio
  24. 6.4.5 Globela Pharma Recent Developments
  25. 6.5 Lupin Pharmaceuticals
  26. 6.5.1 Lupin Pharmaceuticals Company Information
  27. 6.5.2 Lupin Pharmaceuticals Business Overview
  28. 6.5.3 Lupin Pharmaceuticals Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Lupin Pharmaceuticals Vaginitis Drug Product Portfolio
  30. 6.5.5 Lupin Pharmaceuticals Recent Developments
  31. 6.6 Padagis
  32. 6.6.1 Padagis Company Information
  33. 6.6.2 Padagis Business Overview
  34. 6.6.3 Padagis Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Padagis Vaginitis Drug Product Portfolio
  36. 6.6.5 Padagis Recent Developments
  37. 6.7 Perrigo
  38. 6.7.1 Perrigo Company Information
  39. 6.7.2 Perrigo Business Overview
  40. 6.7.3 Perrigo Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Perrigo Vaginitis Drug Product Portfolio
  42. 6.7.5 Perrigo Recent Developments
  43. 6.8 Prestige Consumer Healthcare
  44. 6.8.1 Prestige Consumer Healthcare Company Information
  45. 6.8.2 Prestige Consumer Healthcare Business Overview
  46. 6.8.3 Prestige Consumer Healthcare Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Prestige Consumer Healthcare Vaginitis Drug Product Portfolio
  48. 6.8.5 Prestige Consumer Healthcare Recent Developments
  49. 6.9 Sandoz
  50. 6.9.1 Sandoz Company Information
  51. 6.9.2 Sandoz Business Overview
  52. 6.9.3 Sandoz Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sandoz Vaginitis Drug Product Portfolio
  54. 6.9.5 Sandoz Recent Developments
  55. 6.10 Bayer
  56. 6.10.1 Bayer Company Information
  57. 6.10.2 Bayer Business Overview
  58. 6.10.3 Bayer Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Bayer Vaginitis Drug Product Portfolio
  60. 6.10.5 Bayer Recent Developments
  61. 6.11 Sinopharm Group
  62. 6.11.1 Sinopharm Group Company Information
  63. 6.11.2 Sinopharm Group Business Overview
  64. 6.11.3 Sinopharm Group Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sinopharm Group Vaginitis Drug Product Portfolio
  66. 6.11.5 Sinopharm Group Recent Developments
  67. 6.12 HCPC
  68. 6.12.1 HCPC Company Information
  69. 6.12.2 HCPC Business Overview
  70. 6.12.3 HCPC Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 HCPC Vaginitis Drug Product Portfolio
  72. 6.12.5 HCPC Recent Developments
  73. 6.13 CR-Double Crane Pharmaceuticals
  74. 6.13.1 CR-Double Crane Pharmaceuticals Company Information
  75. 6.13.2 CR-Double Crane Pharmaceuticals Business Overview
  76. 6.13.3 CR-Double Crane Pharmaceuticals Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 CR-Double Crane Pharmaceuticals Vaginitis Drug Product Portfolio
  78. 6.13.5 CR-Double Crane Pharmaceuticals Recent Developments
  79. 6.14 Pfizer
  80. 6.14.1 Pfizer Company Information
  81. 6.14.2 Pfizer Business Overview
  82. 6.14.3 Pfizer Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Pfizer Vaginitis Drug Product Portfolio
  84. 6.14.5 Pfizer Recent Developments
  85. 6.15 Conba
  86. 6.15.1 Conba Company Information
  87. 6.15.2 Conba Business Overview
  88. 6.15.3 Conba Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Conba Vaginitis Drug Product Portfolio
  90. 6.15.5 Conba Recent Developments
  91. 6.16 Kelun Pharmaceuticals
  92. 6.16.1 Kelun Pharmaceuticals Company Information
  93. 6.16.2 Kelun Pharmaceuticals Business Overview
  94. 6.16.3 Kelun Pharmaceuticals Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Kelun Pharmaceuticals Vaginitis Drug Product Portfolio
  96. 6.16.5 Kelun Pharmaceuticals Recent Developments
  97. 6.17 Livzon Pharmaceuticals
  98. 6.17.1 Livzon Pharmaceuticals Company Information
  99. 6.17.2 Livzon Pharmaceuticals Business Overview
  100. 6.17.3 Livzon Pharmaceuticals Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Livzon Pharmaceuticals Vaginitis Drug Product Portfolio
  102. 6.17.5 Livzon Pharmaceuticals Recent Developments
  103. 6.18 Lukang Pharmaceuticals
  104. 6.18.1 Lukang Pharmaceuticals Company Information
  105. 6.18.2 Lukang Pharmaceuticals Business Overview
  106. 6.18.3 Lukang Pharmaceuticals Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Lukang Pharmaceuticals Vaginitis Drug Product Portfolio
  108. 6.18.5 Lukang Pharmaceuticals Recent Developments
  109. 6.19 Luoxin Pharmaceuticals
  110. 6.19.1 Luoxin Pharmaceuticals Company Information
  111. 6.19.2 Luoxin Pharmaceuticals Business Overview
  112. 6.19.3 Luoxin Pharmaceuticals Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Luoxin Pharmaceuticals Vaginitis Drug Product Portfolio
  114. 6.19.5 Luoxin Pharmaceuticals Recent Developments
  115. 6.20 Johnson & Johnson
  116. 6.20.1 Johnson & Johnson Company Information
  117. 6.20.2 Johnson & Johnson Business Overview
  118. 6.20.3 Johnson & Johnson Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Johnson & Johnson Vaginitis Drug Product Portfolio
  120. 6.20.5 Johnson & Johnson Recent Developments
  121. 6.21 Sanofi
  122. 6.21.1 Sanofi Company Information
  123. 6.21.2 Sanofi Business Overview
  124. 6.21.3 Sanofi Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Sanofi Vaginitis Drug Product Portfolio
  126. 6.21.5 Sanofi Recent Developments
  127. 6.22 Shandong Shijiazhuang Pharmaceutical Group
  128. 6.22.1 Shandong Shijiazhuang Pharmaceutical Group Company Information
  129. 6.22.2 Shandong Shijiazhuang Pharmaceutical Group Business Overview
  130. 6.22.3 Shandong Shijiazhuang Pharmaceutical Group Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Shandong Shijiazhuang Pharmaceutical Group Vaginitis Drug Product Portfolio
  132. 6.22.5 Shandong Shijiazhuang Pharmaceutical Group Recent Developments
  133. 6.23 Teva Pharmaceuticals
  134. 6.23.1 Teva Pharmaceuticals Company Information
  135. 6.23.2 Teva Pharmaceuticals Business Overview
  136. 6.23.3 Teva Pharmaceuticals Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Teva Pharmaceuticals Vaginitis Drug Product Portfolio
  138. 6.23.5 Teva Pharmaceuticals Recent Developments
  139. 6.24 Tongfang Pharmaceuticals
  140. 6.24.1 Tongfang Pharmaceuticals Company Information
  141. 6.24.2 Tongfang Pharmaceuticals Business Overview
  142. 6.24.3 Tongfang Pharmaceuticals Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Tongfang Pharmaceuticals Vaginitis Drug Product Portfolio
  144. 6.24.5 Tongfang Pharmaceuticals Recent Developments
  145. 6.25 Wuhan Haite Biopharmaceuticals
  146. 6.25.1 Wuhan Haite Biopharmaceuticals Company Information
  147. 6.25.2 Wuhan Haite Biopharmaceuticals Business Overview
  148. 6.25.3 Wuhan Haite Biopharmaceuticals Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Wuhan Haite Biopharmaceuticals Vaginitis Drug Product Portfolio
  150. 6.25.5 Wuhan Haite Biopharmaceuticals Recent Developments
  151. 6.26 Yuanda Pharmaceuticals
  152. 6.26.1 Yuanda Pharmaceuticals Company Information
  153. 6.26.2 Yuanda Pharmaceuticals Business Overview
  154. 6.26.3 Yuanda Pharmaceuticals Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Yuanda Pharmaceuticals Vaginitis Drug Product Portfolio
  156. 6.26.5 Yuanda Pharmaceuticals Recent Developments
  157. 6.27 Yunnan Baiyao
  158. 6.27.1 Yunnan Baiyao Company Information
  159. 6.27.2 Yunnan Baiyao Business Overview
  160. 6.27.3 Yunnan Baiyao Vaginitis Drug Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Yunnan Baiyao Vaginitis Drug Product Portfolio
  162. 6.27.5 Yunnan Baiyao Recent Developments
7 North America
  1. 7.1 North America Vaginitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Vaginitis Drug Market Size by Country (2021-2026)
  3. 7.3 North America Vaginitis Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Vaginitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Vaginitis Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Vaginitis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Vaginitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Vaginitis Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Vaginitis Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Vaginitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Vaginitis Drug Market Size by Country (2021-2026)
  3. 10.3 South America Vaginitis Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Vaginitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Vaginitis Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Vaginitis Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst